Follow the people · Insider

EF

Ezra M. Friedberg

Insider · Director · PTHS

Ezra M. Friedberg files insider transactions with the SEC as a director of Pelthos Therapeutics (PTHS). We hold 3 disclosed purchases and sales filed since 15 September 2016, 2 of them in the last 90 days.

  • Files forPTHS
  • Disclosed buys and sells3 in all, 2 in the last 90 days
  • Last disclosure7 July 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 14 June 20242 July 2026Director · Pelthos Therapeutics (PTHS)22 Form 4 lines · source: SEC Form 4
  • Filed 21 February 202413 November 2024Director · Chromocell Therapeutics (CHRO)7 Form 4 lines · source: SEC Form 4
  • Filed 13 September 201613 September 2016Director · Kalobios Pharmaceuticals (KBIO)1 Form 4 line · source: SEC Form 4

Everything they disclosed

30 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.